09.11.2017 19:09:02

Regeneron Pharmaceuticals Neutral

Der Analyst Robert W. Baird & Co. Incorporated hat Regeneron Pharmaceuticals Inc. von Underperform auf "Neutral" hochgestuft, aber das Kursziel auf 408 belassen..
Zusammenfassung: Regeneron Pharmaceuticals Inc. Neutral
Unternehmen:
Regeneron Pharmaceuticals Inc.
Analyst:
Robert W. Baird & Co. Incorporated
Kursziel:
$ 408,00
Rating jetzt:
Neutral
Kurs*:
$ 399,50
Abst. Kursziel*:
2,13%
Rating update:
upgrade
Kurs aktuell:
$ 385,22
Abst. Kursziel aktuell:
5,91%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Nachrichten zu Regeneron Pharmaceuticals Inc.

  • Relevant
  • Alle
  • vom Unternehmen
Keine Nachrichten verfügbar.

Aktienempfehlungen zu Regeneron Pharmaceuticals Inc.

  • Alle
  • Buy
  • Hold
  • Sell
09.11.17 Regeneron Pharmaceuticals Neutral Robert W. Baird & Co. Incorporated
09.11.17 Regeneron Pharmaceuticals Sector Perform RBC Capital Markets
20.10.17 Regeneron Pharmaceuticals Underweight Barclays Capital
15.09.17 Regeneron Pharmaceuticals Sector Perform RBC Capital Markets
04.08.17 Regeneron Pharmaceuticals Market Perform BMO Capital Markets
mehr Aktienempfehlungen

Aktien in diesem Artikel

Regeneron Pharmaceuticals Inc. 326,94 -0,49% Regeneron Pharmaceuticals Inc.

Aktienempfehlungen

20.11.17 Dycom Industries Buy B. Riley FBR, Inc.
20.11.17 Fat Brands Buy R. F. Lafferty
20.11.17 Abercrombie & Fitch Underperform Wolfe Research
20.11.17 Theravance Hold Deutsche Bank AG
20.11.17 Viacom Hold Deutsche Bank AG
20.11.17 RTL overweight JP Morgan Chase & Co.
20.11.17 ProSiebenSat1 Media overweight JP Morgan Chase & Co.
20.11.17 Laureate Educatio a Equal weight Barclays Capital
20.11.17 XPO Logistics Outperform Oppenheimer & Co. Inc.
20.11.17 Penn National Gaming overweight Barclays Capital
20.11.17 Nxt-ID Buy Maxim Group
20.11.17 Marvell Technology Group Buy The Benchmark Company
20.11.17 National Vision Neutral UBS AG
20.11.17 Luxoft a Neutral UBS AG
20.11.17 DS a Hold Canaccord Adams
20.11.17 BP Midstream Partners LP Registered Buy UBS AG
20.11.17 ForeScout Technologies Buy UBS AG
20.11.17 Barclays buy Merrill Lynch & Co., Inc.
20.11.17 Gladstone Investment Neutral Wedbush Morgan Securities Inc.
20.11.17 Prothena Neutral Wedbush Morgan Securities Inc.
20.11.17 Jack in the Box Neutral Wedbush Morgan Securities Inc.
20.11.17 Semtech Buy BWS Financial
20.11.17 Manitowoc Company Buy Seaport Global Securities
20.11.17 Qudia a Buy Needham & Company, LLC
20.11.17 Corium International Buy Needham & Company, LLC
20.11.17 Enphase Energy Buy Craig Hallum
20.11.17 Knowles Buy Lake Street
20.11.17 STAAR Surgical Company Buy The Benchmark Company
20.11.17 Targa Resources Buy Stifel, Nicolaus & Co., Inc.
20.11.17 Nemetschek Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.11.17 Walmart Neutral Goldman Sachs Group Inc.
20.11.17 Amazon buy Nomura
20.11.17 LEONI kaufen DZ BANK
20.11.17 Rightmove Sector Perform RBC Capital Markets
20.11.17 STMicroelectronics Reduce Kepler Cheuvreux
20.11.17 Sanofi buy Kepler Cheuvreux
20.11.17 Abercrombie & Fitch Market Perform Telsey Advisory Group
20.11.17 First Savings Financial Group Buy Maxim Group
20.11.17 Kindred Healthcare Hold Stifel, Nicolaus & Co., Inc.
20.11.17 Volkswagen (VW) vz buy UBS AG
20.11.17 Scout24 overweight Morgan Stanley
20.11.17 Zalando overweight Morgan Stanley
20.11.17 Volkswagen (VW) vz kaufen Norddeutsche Landesbank (Nord/LB)
20.11.17 Siemens buy UBS AG
20.11.17 Stabilus accumulate equinet AG
20.11.17 Foot Locker Market Perform Telsey Advisory Group
20.11.17 Campbell Soup Sector Perform RBC Capital Markets
20.11.17 Assicurazioni Generali Underperform Bernstein Research
20.11.17 Swiss Re market-perform Bernstein Research
20.11.17 Zurich Insurance Underperform Bernstein Research